Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 370,890 |
|
|||||
| News | - | ||||||
| Day High | 9.43 | Low High |
|||||
| Day Low | 8.96 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Phathom Pharmaceuticals Inc | PHAT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.08 | 0.88% | 9.18 | 17:16:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.08 | 8.96 | 9.43 | 9.18 | 9.10 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,035 | 370,890 | $ 9.20 | $ 3,410,726 | - | 6.065 - 17.0185 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:38:56 | 4 | $ 8.90 | USD |
Phathom Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 536.82M | 58.48M | - | 682k | -201.59M | -3.45 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Phathom Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHAT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.48 | 9.88 | 8.74 | 9.05 | 523,357 | -0.30 | -3.16% |
| 1 Month | 10.62 | 12.27 | 8.74 | 10.44 | 758,282 | -1.44 | -13.56% |
| 3 Months | 6.66 | 12.27 | 6.065 | 9.57 | 917,687 | 2.52 | 37.84% |
| 6 Months | 9.03 | 12.27 | 6.065 | 8.90 | 735,437 | 0.15 | 1.66% |
| 1 Year | 10.21 | 17.0185 | 6.065 | 10.08 | 545,305 | -1.03 | -10.09% |
| 3 Years | 39.81 | 40.90 | 5.84 | 11.70 | 324,321 | -30.63 | -76.94% |
| 5 Years | 24.315 | 64.54 | 5.84 | 14.80 | 246,609 | -15.14 | -62.25% |
Phathom Pharmaceuticals Description
| Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection. |
